Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by Gustoeson Jan 15, 2015 8:36am
106 Views
Post# 23322050

RE:unseen catlaysts

RE:unseen catlaysts
Aubrey wrote: The purpose for the $50M raise has not yet been revealed. From Dr Lilge ..(my take away form the AGM)..the best aspect of our PDCs is their versatility..they can be used to destroy breast tumors,etc. because the treatment can be controlled to do no harm, with inteligent degign..  We will soon see new applications, and it is not a streatch to tackle breast tumors or others given what TLT has accomplished so far. Money will be raised but only for a large purpose. Otherwise, TLT does not need the cash. Roger will allways increase shareholder value. He owns 5M+ shares.
  The traders who sell for less decrease shareholder value. Greed and selfishness rules their life. Next their health fails, and they don't see the connection. Greed and selfishness is harmful to ones health and wealth and harms the whole community. True Alpha comes from being of benefit to everyone and everything one does. People often try to take advantage of me, where are they today? I don't have to step on people, they step on themselves.
TLT could have been over $1.00 ...dudes, a double is not a lot of money, that thinking will keep you poor,
  cheers to all     Aubrey 


I like the way you think. Big picture for this company is something we should all be speculating about... to get in early could be very rewarding. If they take financing, it will be for a good reason.

I'm leaning towards their lead PDC's requiring a new division and expansions of PDC division.

They don't need the money necessarily but could use it for shareholder value.

PDC - expansions of PDC department for diagnostic agent for screening and surgical assistance.  Also commercialization of TLC3000

PDI/Bacteria - huge applications. disinfection/sterilization, treatment of drug resistance bacteria.

Go go gadget TLD1433!!

https://www.google.com/patents/WO2013158550A1

https://mcfarland.acadiau.ca/tl_files/sites/mcfarland/images/Publications%20Page/Our%20Publications/arenas13-pdpdt.pdf
Bullboard Posts